Eurofins Scientific (ERF)
Testing-laboratory network acquirer. Eurofins Scientific is listed on the Euronext Paris and reports in EUR. compounders.ai reads its annual filings and shows reported operating profit next to normalized EBITA under one published rulebook, every figure linked to the filing it was read from.
- Archetype
- Distribution / services roll-up
- Listing
- Euronext Paris: ERF (listing key
XPAR-ERF) - Country
- Luxembourg
- Reporting currency
- EUR
- Filing source
- ESEF package (native)
- Latest filing on record
- Annual financial report (ESEF package) for the fiscal year ended 2024-12-31 — Eurofins Scientific (3 filings on record)
- Fiscal years published
- FY2020–FY2024
- Normalized EBITA published
- FY2023
Key figures, FY2024
Fiscal year ended 31 Dec 2024, in EUR as reported. Published 19 Oct 2026 under ruleset 1.4.0; read for this page on 20 Oct 2026. Each figure links to the filing it was read from; a computed figure links to its primary citation.
| Figure | FY2024 | Source |
|---|---|---|
| Income statement | ||
| Revenue | EUR 6,951 million | Annual financial report (ESEF package) for the fiscal year ended 2024-12-31 — Eurofins Scientific · ifrs-full:Revenue · as filed |
| Reported operating profit | EUR 680.5 million | Annual financial report (ESEF package) for the fiscal year ended 2024-12-31 — Eurofins Scientific · ifrs-full:ProfitLossFromOperatingActivities · as filed |
| Reported operating margin | 9.8% | Annual financial report (ESEF package) for the fiscal year ended 2024-12-31 — Eurofins Scientific · ifrs-full:ProfitLossFromOperatingActivities · computed from cited lines |
| Normalized EBITA | Not published for FY2024 | |
| Normalized EBITA margin | Not published for FY2024 | |
| Normalized EBITDA | Not published for FY2024 | |
| Returns on capital | ||
| ROIC incl. goodwill | Not published for FY2024 | |
| ROIC excl. goodwill | Not published for FY2024 | |
| ROIIC, 3 years | Not published for FY2024 | |
| Balance sheet and cash | ||
| Net debt | Not published for FY2024 | |
| Net debt to EBITDA | Not published for FY2024 | |
| FCF before acquisitions | Not published for FY2024 | |
| FCF available to shareholders (FCFA2S) | Not published for FY2024 | |
Earlier years (FY2020–FY2023) are in the terminal's tabs below.
In the terminal
- Eurofins Scientific: Financials
- Eurofins Scientific: Normalization
- Eurofins Scientific: Growth
- Eurofins Scientific: KPIs
- Eurofins Scientific: Returns
- Eurofins Scientific: Sources
How the figures are made: methodology · glossary · how to cite them: citation guidelines.